Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast-enhanced MRI.
Li, Ka-Loh PhD 1; Wilmes, Lisa J. PhD 1; Henry, Roland G. PhD 1; Pallavicini, Maria G. PhD 2,3; Park, John W. MD 2; Hu-Lowe, Dana D. PhD 4; McShane, Teresa M. DVM, PhD 5; Shalinsky, David R. PhD 4; Fu, Y-J PhD 1; Brasch, Robert C. MD 1; Hylton, Nola M. PhD 1,*
Journal of Magnetic Resonance Imaging.
22(4):511-519, October 2005.
(Format: HTML, PDF)